Bi-Flow is first bidirectional femoral arterial cannula validated for 29 days’ use LONDON--(BUSINESS WIRE)-- LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, ...

The new report entitled Extracorporeal Membrane Oxygenation (ECMO) Market by Component (Accessories, Cannula, Controllers, Oxygenator, Pumps), Application (ECPR ...

The current trend of using two cannulas to place most newborns in respiratory failure on life-sustaining ECMO, one in the right internal jugular vein and a second in the right common carotid artery, ...

You may think of ventilators as the last line of defense for patients who are critically ill with COVID-19. But that’s not always the case. Next-level life support exists for some of the sickest ...

Extracorporeal membrane oxygenation (ECMO) is a method of providing lung and heart support to patients with inadequate blood perfusion in the body, or gas exchange in the lungs. Blood is pumped from ...

The global arterial cannula market has witnessed remarkable growth, reaching a market value of USD 21 billion in 2023. With a robust compound annual growth rate (CAGR) of 6.6%, this market is ...

NEWARK, Del, Dec. 13, 2022 (GLOBE NEWSWIRE) -- A recently published study by FMI expects the global arterial cannula market to augment at a 6.6% CAGR from 2022 to 2032. By the end of the said ...

LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Bi-Flow Extracorporeal Membrane Oxygenation (ECMO) cannula earned ...

Bi-Flow is first bidirectional femoral arterial cannula validated for 29 days' use LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Bi-Flow ...